14-day Premium Trial Subscription Sign Up For FreeGet Free

CytomX Therapeutics Stock News NASDAQ:CTMX

SOUTH SAN FRANCISCO, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational conditionally activated therapeutics based on its Probody ® technology platform, today announced that Sean McCarthy, D.Phil., president, chief executive officer, and chairman, will participate in a virtual fireside chat at the H.C. Wainwright 23 rd Annual Global Investment Conference, being held from September 13-15, 2021. In addition, management will be available for one-on-one meetings with investors who are registered to attend the conference. Read more
Here''s a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV ) Alkermes plc (NASDAQ: ALKS ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX ) Gilead Sciences, Inc. (NASDAQ: GILD ) GlaxoSmithKline plc (NYSE: GSK ) ( announced FDA approval for label expansion for its Jemperli) Novo Nordisk A/S (NYSE: NVO ) Innoviva, Inc. (NASDAQ: INVA ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI ) Omega Therapeutics, Inc. (NASDAQ: OMGA ) (IPOed July 30) Pfizer, Inc. (NYSE: PFE ) Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) ResMed Inc. (NYSE: RMD ) TScan Therapeutics, Inc. (NASDAQ: TCRX ) Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX ) West Pharmaceutical Services, Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Aug. 18) Absci Corporation (NASDAQ: ABSI ) Achieve Life Sciences, Inc. (NASDAQ: ACHV ) Adaptive Biotechnologies Corporation (NASDAQ: ADPT ) ADMA Biologics, Inc. (NASDAQ: ADMA ) Akouos, Inc. (NASDAQ: AKUS ) Angion Biomedica Corp. (NASDAQ: ANGN ) Aptinyx Inc. (NASDAQ: APTX ) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) AVROBIO, Inc. (NASDAQ: AVRO ) Axsome Therapeutics, Inc. (NASDAQ: AXSM ) Biomea Fusion, Inc. (NASDAQ: BMEA ) BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV ) Catalyst Biosciences, Inc. (NASDAQ: CBIO ) Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI ) Chemomab Therapeutics Ltd. (NASDAQ: CMMB ) CNS Pharmaceuticals, Inc. (NASDAQ: CNSP ) Compass Therapeutics, Inc. (OTC: CMPX ) ContraFect Corporation (NASDAQ: CFRX ) CymaBay Therapeutics, Inc. (NASDAQ: CBAY ) CytomX Therapeutics, Inc. (NASDAQ: CTMX ) Epizyme, Read more

CytomX Therapeutics Announces New Employment Inducement Grants

12:00pm, Tuesday, 17'th Aug 2021 Intrado Digital Media
SOUTH SAN FRANCISCO, Calif., Aug. 17, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage, oncology-focused biopharmaceutical company pioneering a novel class of investigational conditionally activated antibody therapeutics based on its Probody® technology platform, today announced that on August 16, 2021, the Company granted seven new employees options to purchase a total of 172,600 shares of the Companys common stock at an exercise price per share equal to $4.81, which was the closing trading price on August 16, 2021, the date of the grant. Read more
Here''s a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (NASDAQ: ADGI ) (IPOed Friday) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Cytek Biosciences, Inc. (NASDAQ: CTKB ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Eliem Therapeutics, Inc. (NASDAQ: ELYM ) (IPOed Monday) Erasca, Inc. (NASDAQ: ERAS ) (IPOed July 16) Fulcrum Therapeutics, Inc. (NASDAQ: FULC ) (reacted to positive analyst actions following a positive clinical readout) IN8bio, Inc. (NASDAQ: INAB ) Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD ) Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI ) (announced second-quarter results) Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE ) Rani Therapeutics Holdings, Inc. (NASDAQ: RANI ) (IPOed July 30) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Aug. 11) Adicet Bio, Inc. (NASDAQ: ACET ) Akero Therapeutics, Inc. (NASDAQ: AKRO ) Allogene Therapeutics, Inc. (NASDAQ: ALLO ) Aptose Biosciences Inc. Read more
Here''s a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (NASDAQ: ADGI ) (IPOed Friday) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Axonics, Inc. (NASDAQ: AXNX ) BioLife Solutions, Inc. (NASDAQ: BLFS ) (announced a deal to buy privately-held Sexton Biotech to expand cell and gene therapy tools portfolio) BioNTech SE (NASDAQ: BNTX ) (reacted to its quarterly results and raised vaccine sales forecast) Caribou Biosciences, Inc. (NASDAQ: CRBU ) (IPOed July 23) Cortexyme, Inc. (NASDAQ: CRTX ) (announced its second-quarter results) Cytokinetics, Incorporated (NASDAQ: CYTK ) Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Edwards Lifesciences Corporation (NYSE: EW ) Eli Lilly and Company (NYSE: LLY ) Impel NeuroPharma, Inc. (NASDAQ: IMPL ) (announced publication of positive Phase 3 data for migraine treatment) Intersect ENT, Inc. Read more

CytomX Therapeutics, inc (CTMX) Q2 2021 Earnings Call Transcript

03:30pm, Saturday, 07'th Aug 2021 The Motley Fool
CTMX earnings call for the period ending June 30, 2021. Read more
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational conditionally activated therapeutics based on its Probody® technology platform, today reported second quarter 2021 financial results and provided a business update. Read more
SOUTH SAN FRANCISCO, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational conditionally activated therapeutics based on its Probody ® technology platform, today announced that it will report second quarter 2021 financial results on Thursday, August 5, 2021, after the close of U.S. markets. Following the announcement, the Company will host a conference call and webcast at 5:00 p.m. ET / 2:00 p.m. PT to discuss the results and provide a corporate update. Read more
Here''s a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI ) (IPOed Thursday) Arvinas, Inc. (NASDAQ: ARVN ) BioNTech SE (NASDAQ: BNTX ) ( disclosed plans to make mRNA vaccine for malaria by 2022) Cassava Sciences, Inc. (NASDAQ: SAVA ) (announced positive data for SavaDx, an investigational diagnostic/biomarker to detect Alzheimer''s disease with a simple blood test) Eli Lilly and Company (NYSE: LLY ) Moderna, Inc. (NASDAQ: MRNA ) Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE ) NanoVibronix, Inc. (NASDAQ: NAOV ) (announced first shipment of its next generation pain management device, PainShield Plus) Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) Sight Sciences, Inc. (NASDAQ: SGHT ) (IPOed July 15) Translate Bio, Inc. (NASDAQ: TBIO ) (moved on positive analyst action) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 26) 23andMe Holding Co. (NASDAQ: ME ) AbCellera Biologics Inc. Read more
Here''s a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22) Bio-Techne Corporation (NASDAQ: TECH ) BioNTech SE (NASDAQ: BNTX ) (announced a collaboration with Biovac to manufacture COVID-19 shots in South Africa) Bristol-Myers Squibb Company (NYSE: BMY ) Cassava Sciences, Inc. (NASDAQ: SAVA ) Century Therapeutics, Inc. (NASDAQ: IPSC ) Cortexyme, Inc. (NASDAQ: CRTX ) (announced positive data for pipeline asset in periodontal disease) Eli Lilly and Company (NYSE: LLY ) Erasca, Inc. (NASDAQ: ERAS ) (IPOed July 16) Horizon Therapeutics Public Limited Company (NASDAQ: HZNP ) Legend Biotech Corporation (NASDAQ: LEGN ) NeuroMetrix, Inc. (NASDAQ: NURO ) (reacted to its second-quarter results) Novo Nordisk A/S (NYSE: NVO ) PLx Pharma Inc. (NASDAQ: PLXP ) ResMed Inc. (NYSE: RMD ) Sight Sciences, Inc. (NASDAQ: SGHT ) (IPOed July 15) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 22) 23andMe Holding Co. Read more
Here''s a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated (NASDAQ: CYTK ) ( announced topline results from Cohorts 1 and 2 of the Phase 2 study of CK-274 in obstructive outflow disease in hypertrophic cardiomyopathy) Forward Pharma A/S (NASDAQ: FWP ) ResMed Inc. (NYSE: NRMD) Legend Biotech Corporation (NASDAQ: LEGN ) Moderna, Inc. (NASDAQ: MRNA ) ( extended gains on recent momentum) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 19) 4D pharma plc (NASDAQ: LBPS ) Adaptimmune Therapeutics plc (NASDAQ: ADAP ) Adverum Biotechnologies, Inc. (NASDAQ: ADVM ) Aerovate Therapeutics, Inc. (NASDAQ: AVTE ) (IPOed June 30) Agile Therapeutics, Inc. (NASDAQ: AGRX ) Allena Pharmaceuticals, Inc. (NASDAQ: ALNA ) Alzamend Neuro, Inc. (NASDAQ: ALZN ) Aptose Biosciences Inc. (NASDAQ: APTO ) ARCA biopharma, Inc. (NASDAQ: ABIO ) Ascendis Pharma A/S (NASDAQ: ASND ) Assembly Biosciences, Inc. Read more

CytomX Therapeutics Inc Shares Near 52-Week Low - Market Mover

03:47pm, Saturday, 17'th Jul 2021 Kwhen Finance
CytomX Therapeutics Inc (CTMX) shares closed today at 1.8% above its 52 week low of $5.69, giving the company a market cap of $376M. The stock is currently down 11.6% year-to-date, down 32.0% over the past 12 months, and down 45.8% over the past five years. This week, the Dow Jones Industrial Average rose 1.6%, and the S&P 500 rose 0.9%. Trading Activity Trading volume this week was 19.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold.The stock closed at 2.0% lower than its 5-day moving average, 8.5% lower than its 20-day moving average, and 24.2% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -59.3% The company's stock price performance over the past 12 months lags the peer average by 71.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected] © 2020 Kwhen Inc. Read more

CytomX Therapeutics Inc Shares Near 52-Week Low - Market Mover

02:02am, Saturday, 17'th Jul 2021 Kwhen Finance
CytomX Therapeutics Inc (CTMX) shares closed today at 0.4% above its 52 week low of $5.69, giving the company a market cap of $376M. The stock is currently down 11.6% year-to-date, down 32.9% over the past 12 months, and down 45.6% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 1.0%. Trading Activity Trading volume this week was 34.9% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -59.3% The company's stock price performance over the past 12 months lags the peer average by 68.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected] © 2020 Kwhen Inc. Read more

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE